ticlopidine has been researched along with Age-Related Osteoporosis in 7 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Mechanisms through which polypharmacy may increase adverse health outcomes include decreased adherence, increased drug side effects, higher use of potentially inappropriate medications, and more frequent drug-drug interactions." | 2.52 | Appropriate prescribing and important drug interactions in older adults. ( Paauw, DS; Wallace, J, 2015) |
| " In order to achieve the desired results and, as with all medications, PPIs should always be used appropriately taking care never to exceed correct dosage and duration." | 2.47 | Proton pump inhibitors in rheumatic diseases: clinical practice, drug interactions, bone fractures and risk of infections. ( Ferraccioli, GF; Gremese, E; Laria, A; Zoli, A, 2011) |
| " Despite the widespread usage and favorable safety profile, much attention has focused recently on potential adverse events associated with use." | 2.46 | Safety of proton pump inhibitors: current evidence for osteoporosis and interaction with antiplatelet agents. ( Johnson, DA, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wallace, J | 1 |
| Paauw, DS | 1 |
| Johnson, DA | 1 |
| Madanick, RD | 1 |
| Vestergaard, P | 1 |
| Steinberg, TH | 2 |
| Schwarz, P | 1 |
| Jørgensen, NR | 1 |
| Laria, A | 1 |
| Zoli, A | 1 |
| Gremese, E | 1 |
| Ferraccioli, GF | 1 |
| Messinger-Rapport, BJ | 1 |
| Morley, JE | 1 |
| Thomas, DR | 1 |
| Gammack, JK | 1 |
| Su, X | 1 |
| Floyd, DH | 1 |
| Hughes, A | 1 |
| Xiang, J | 1 |
| Schneider, JG | 1 |
| Uluckan, O | 1 |
| Heller, E | 1 |
| Deng, H | 1 |
| Zou, W | 1 |
| Craft, CS | 1 |
| Wu, K | 1 |
| Hirbe, AC | 1 |
| Grabowska, D | 1 |
| Eagleton, MC | 1 |
| Townsley, S | 1 |
| Collins, L | 1 |
| Piwnica-Worms, D | 1 |
| Novack, DV | 1 |
| Conley, PB | 1 |
| Hurchla, MA | 1 |
| Rogers, M | 1 |
| Weilbaecher, KN | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Institute of Emergency and Critical Care Medicine , School of Yang-Ming University[NCT01588886] | 9,000 participants (Actual) | Observational | 2012-03-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for ticlopidine and Age-Related Osteoporosis
| Article | Year |
|---|---|
Appropriate prescribing and important drug interactions in older adults.
Topics: Aged; Aged, 80 and over; Calcium Channel Blockers; Clopidogrel; Drug Combinations; Drug Interactions | 2015 |
Safety of proton pump inhibitors: current evidence for osteoporosis and interaction with antiplatelet agents.
Topics: Clopidogrel; Cytochrome P-450 Enzyme System; Drug Interactions; Evidence-Based Medicine; Hip Fractur | 2010 |
Proton pump inhibitor side effects and drug interactions: much ado about nothing?
Topics: Anemia, Iron-Deficiency; Anti-Ulcer Agents; Clopidogrel; Drug Interactions; Fractures, Spontaneous; | 2011 |
Proton pump inhibitors in rheumatic diseases: clinical practice, drug interactions, bone fractures and risk of infections.
Topics: Anticoagulants; Aryl Hydrocarbon Hydroxylases; Aspirin; Calcium, Dietary; Clopidogrel; Clostridioide | 2011 |
3 other studies available for ticlopidine and Age-Related Osteoporosis
| Article | Year |
|---|---|
Use of the oral platelet inhibitors dipyridamole and acetylsalicylic acid is associated with increased risk of fracture.
Topics: Acute Coronary Syndrome; Adult; Aged; Aspirin; Case-Control Studies; Clopidogrel; Dipyridamole; Drug | 2012 |
Clinical update on nursing home medicine: 2011.
Topics: Anti-Ulcer Agents; Anticoagulants; Atrial Fibrillation; Clopidogrel; Clostridioides difficile; Delir | 2011 |
The ADP receptor P2RY12 regulates osteoclast function and pathologic bone remodeling.
Topics: Adenosine Diphosphate; Animals; Arthritis, Experimental; Bone Neoplasms; Bone Remodeling; Bone Resor | 2012 |